InsiderTrades.com logo

GRTX Insider Trading

Insider Ownership Percentage: 12.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Galera Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Galera Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Galera Therapeutics Share Price & Price History

Current Price: $0.03
Price Change: ▲ Price Increase of +0.0012 (5.00%)
As of 12/4/2025 04:57 PM ET

This chart shows the closing price history over time for GRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Galera Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2023Mark BachledaInsiderBuy11,000$2.25$24,750.0011,000View SEC Filing Icon  
3/13/2023Chris DegnanCFOBuy10,000$1.96$19,600.0010,000View SEC Filing Icon  
3/10/2023Mel SorensenCEOBuy100,000$1.68$168,000.00332,044View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Galera Therapeutics (NASDAQ:GRTX)

50.77% of Galera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GRTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Galera Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/3/2024GSA Capital Partners LLP3,632,627$0.51M0.0%-6.7%6.679%Search for SEC Filing on Google Icon
1/31/2024abrdn plc898,374$0.13M0.0%N/A1.652%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.2,005,054$6.26M1.0%-4.5%4.673%Search for SEC Filing on Google Icon
8/4/2023Parallel Advisors LLC7,867$25K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/2/2023Baystate Wealth Management LLC47,695$0.15M0.0%N/A0.111%Search for SEC Filing on Google Icon
7/27/2023Pinnacle Associates Ltd.47,695$0.15M0.0%N/A0.111%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.20,000$62K0.0%N/A0.047%Search for SEC Filing on Google Icon
7/21/2023Global Assets Advisory LLC24,500$73K0.1%N/A0.057%Search for SEC Filing on Google Icon
7/11/2023Good Life Advisors LLC11,250$35K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/12/2023Sectoral Asset Management Inc.2,098,565$5.37M1.0%+25.9%4.891%Search for SEC Filing on Google Icon
5/12/2023Mirabella Financial Services LLP57,000$6.66M1.0%N/A0.133%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC20,195$52K0.0%N/A0.047%Search for SEC Filing on Google Icon
4/14/2023Raymond James Financial Services Advisors Inc.23,475$60K0.0%N/A0.055%Search for SEC Filing on Google Icon
2/10/2023Sectoral Asset Management Inc.1,666,666$2.48M0.5%N/A5.848%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc151,777$0.20M0.0%+281.6%0.566%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc39,775$0.15M0.0%N/A0.150%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC96,027$0.44M0.0%N/A0.363%Search for SEC Filing on Google Icon
2/8/2022Raymond James Financial Services Advisors Inc.22,311$0.10M0.0%-26.3%0.084%Search for SEC Filing on Google Icon
1/28/2022Taylor Wealth Management Partners11,635$53K0.0%-79.9%0.044%Search for SEC Filing on Google Icon
1/25/2022Belvedere Trading LLC96,486$0.26M0.0%N/A0.365%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP300,605$2.44M0.5%+36.7%1.137%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP83,050$0.67M0.0%-28.7%0.315%Search for SEC Filing on Google Icon
11/12/2021AIGH Capital Management LLC2,036,495$16.50M3.5%+0.7%7.724%Search for SEC Filing on Google Icon
10/26/2021Taylor Wealth Management Partners58,012$0.47M0.2%-11.0%0.220%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC118,548$1.17M0.0%N/A0.450%Search for SEC Filing on Google Icon
8/16/2021State Street Corp15,964$0.16M0.0%-87.5%0.061%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp14,795$0.15M0.0%-84.4%0.056%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Galera Therapeutics logo
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.
Read More on Galera Therapeutics

Today's Range

Now: $0.03
Low: $0.02
High: $0.03

50 Day Range

MA: $0.02
Low: $0.02
High: $0.03

52 Week Range

Now: $0.03
Low: $0.02
High: $0.06

Volume

11,190 shs

Average Volume

102,288 shs

Market Capitalization

$1.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91